Evaxion A (EVAX) Receivables - Net (2019 - 2023)
Evaxion A posted quarterly Receivables - Net of $2.0 million for Q4 2023, down 30.06% year-on-year from $2.8 million in Q4 2022, and down 30.06% on a QoQ basis from $2.8 million in Q4 2022.
Evaxion A (EVAX) has 5 years of Receivables - Net data on file, last reported at $2.0 million in Q4 2023.
- For the quarter ending Q4 2023, Receivables - Net fell 30.06% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2023 stood at $2.0 million (down 30.06% YoY), and the FY2023 full-year result was $2.0 million, down 30.06% from the prior year.
- Receivables - Net for Q4 2023 stood at $2.0 million, down from $2.8 million in the prior quarter.
- Across five years, Receivables - Net topped out at $2.8 million in Q4 2022 and bottomed at $575000.0 in Q4 2019.
- The 5-year median for Receivables - Net is $1.6 million (2020), against an average of $1.6 million.
- The widest annual swing landed in 2020, when Receivables - Net jumped 170.09%; it then tumbled 30.06% in 2023.
- A 5-year view of Receivables - Net shows it stood at $575000.0 in 2019, then jumped by 170.09% to $1.6 million in 2020, then decreased by 26.72% to $1.1 million in 2021, then soared by 145.25% to $2.8 million in 2022, then tumbled by 30.06% to $2.0 million in 2023.
- The last three Receivables - Net figures came in at $2.0 million (Q4 2023), $2.8 million (Q4 2022), and $1.1 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.95 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Dec 31, 2020 | 1.55 Mn |
| Dec 31, 2020 | 1.55 Mn |
| Dec 31, 2019 | 575,000.00 |
| Dec 31, 2019 | 575,000.00 |